ロード中...
How do CARs work?: Early insights from recent clinical studies targeting CD19
Second-generation chimeric antigen receptors (CARs) are powerful tools to redirect antigen-specific T cells independently of HLA-restriction. Recent clinical studies evaluating CD19-targeted T cells in patients with B-cell malignancies demonstrate the potency of CAR-engineered T cells. With results...
保存先:
主要な著者: | , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
Landes Bioscience
2012
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3525612/ https://ncbi.nlm.nih.gov/pubmed/23264903 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.22524 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|